NCT07437950

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-10-14Est. Completion: 2029-05-31

Enrollment target: 126 participants

Acute Myeloid Leukemia

This phase II MyeloMATCH treatment trial compares cytarabine with daunorubicin versus cytarabine with daunorubicin and v…

Birmingham, United StatesEst. completion Dec 31, 2027

Advanced Solid TumorTNBC - Triple-Negative Breast CancerGastric CancerLeukemia Acute Myeloid Leukemia (AML)

This study is a multiple cohort, multicenter, open-label Phase 1 study with dose-escalation substudies investigating int…

New Haven, United StatesEst. completion Dec 24, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.